Testicular dose during prophylaxis of heterotopic ossification with radiation therapy

Waleed Fouad Mourad, John K. Ma, Satyaseelan Packianathan, Weisi Yan, Sherif G. Shaaban, Edward M. Marchan, Lamiaa E. Abdallah, Rei He, Paul N. Mobit, Chunli Yang, Srinivasan Vijayakumar

Research output: Contribution to journalArticle

Abstract

Aim: A single-institution, retrospective study was performed to investigate potential techniques to minimize radiation exposure to the testicles during heterotopic ossification (HO) prophylaxis. We report the impact of splitbeam technique (SBT) and different photon energies on the total dose of radiation received by the testicles during prophylaxis of HO. Materials and Methods: Between 2008 and 2010, we identified 64 patients with traumatic acetabular fractures who underwent surgery followed by radiation therapy (RT) without testicular shielding. Postoperative RT was delivered within 72 h in a single fraction of 700 cGy using 6-18 MV photons, without testicular shielding due to patient refusal. All patients underwent 3-D RT planning in which the testicles were contoured as a region of interest and dosevolume histograms (DVH) were generated. Additional treatment planning trials were created for each patient by utilizing a SBT medially and by using different photon energies (6, 10 and 18 MV) to study the effects of these maneuvers on the delivered dose to the testicles. Results: In reviewing the DVH, it was noted that the mean dose delivered to the testicles was 10 cGy (range=3-40). The maximum dose was 31 cGy (range=7-430). When SBT was utilized, a significant reduction in the mean (44%) and maximum (47%) doses delivered to the testicles was noted. Further reductions in the mean (26%) and maximum (14%) doses were achieved by using higher-energy (10-18 MV) beams. The radiation doses to the testicles from the CT simulation and the two portal images were estimated to be 4 and 1.5 cGy, respectively. Conclusion: Low-dose prophylactic RT to prevent HO around the hip causes a low, but likely biologically meaningful, radiation dose to be delivered to the testicles. This dose could be further reduced by using a medial SBT and photon energies above 6 MV. Testicular shielding should be offered to all male patients receiving such RT. In addition, all patients should be informed about the consequences of testicular radiation as part of their informed consent.

Original languageEnglish (US)
Pages (from-to)461-466
Number of pages6
JournalIn Vivo
Volume31
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Heterotopic Ossification
Radiotherapy
Dosimetry
Testis
Photons
Shielding
Radiation
Planning
Surgery
Informed Consent
Hip
Retrospective Studies

Keywords

  • Acetabular fracture
  • Heterotopic ossification (HO)
  • Indomethacin
  • Megavoltage photon
  • Radiation prophylaxis
  • Radiation therapy (RT)
  • Split-beam technique
  • Testicular dose

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Mourad, W. F., Ma, J. K., Packianathan, S., Yan, W., Shaaban, S. G., Marchan, E. M., ... Vijayakumar, S. (2017). Testicular dose during prophylaxis of heterotopic ossification with radiation therapy. In Vivo, 31(3), 461-466. https://doi.org/10.21873/invivo.11084

Testicular dose during prophylaxis of heterotopic ossification with radiation therapy. / Mourad, Waleed Fouad; Ma, John K.; Packianathan, Satyaseelan; Yan, Weisi; Shaaban, Sherif G.; Marchan, Edward M.; Abdallah, Lamiaa E.; He, Rei; Mobit, Paul N.; Yang, Chunli; Vijayakumar, Srinivasan.

In: In Vivo, Vol. 31, No. 3, 01.05.2017, p. 461-466.

Research output: Contribution to journalArticle

Mourad, WF, Ma, JK, Packianathan, S, Yan, W, Shaaban, SG, Marchan, EM, Abdallah, LE, He, R, Mobit, PN, Yang, C & Vijayakumar, S 2017, 'Testicular dose during prophylaxis of heterotopic ossification with radiation therapy', In Vivo, vol. 31, no. 3, pp. 461-466. https://doi.org/10.21873/invivo.11084
Mourad WF, Ma JK, Packianathan S, Yan W, Shaaban SG, Marchan EM et al. Testicular dose during prophylaxis of heterotopic ossification with radiation therapy. In Vivo. 2017 May 1;31(3):461-466. https://doi.org/10.21873/invivo.11084
Mourad, Waleed Fouad ; Ma, John K. ; Packianathan, Satyaseelan ; Yan, Weisi ; Shaaban, Sherif G. ; Marchan, Edward M. ; Abdallah, Lamiaa E. ; He, Rei ; Mobit, Paul N. ; Yang, Chunli ; Vijayakumar, Srinivasan. / Testicular dose during prophylaxis of heterotopic ossification with radiation therapy. In: In Vivo. 2017 ; Vol. 31, No. 3. pp. 461-466.
@article{e90ffc6ddf6041baa350606187aa82d2,
title = "Testicular dose during prophylaxis of heterotopic ossification with radiation therapy",
abstract = "Aim: A single-institution, retrospective study was performed to investigate potential techniques to minimize radiation exposure to the testicles during heterotopic ossification (HO) prophylaxis. We report the impact of splitbeam technique (SBT) and different photon energies on the total dose of radiation received by the testicles during prophylaxis of HO. Materials and Methods: Between 2008 and 2010, we identified 64 patients with traumatic acetabular fractures who underwent surgery followed by radiation therapy (RT) without testicular shielding. Postoperative RT was delivered within 72 h in a single fraction of 700 cGy using 6-18 MV photons, without testicular shielding due to patient refusal. All patients underwent 3-D RT planning in which the testicles were contoured as a region of interest and dosevolume histograms (DVH) were generated. Additional treatment planning trials were created for each patient by utilizing a SBT medially and by using different photon energies (6, 10 and 18 MV) to study the effects of these maneuvers on the delivered dose to the testicles. Results: In reviewing the DVH, it was noted that the mean dose delivered to the testicles was 10 cGy (range=3-40). The maximum dose was 31 cGy (range=7-430). When SBT was utilized, a significant reduction in the mean (44{\%}) and maximum (47{\%}) doses delivered to the testicles was noted. Further reductions in the mean (26{\%}) and maximum (14{\%}) doses were achieved by using higher-energy (10-18 MV) beams. The radiation doses to the testicles from the CT simulation and the two portal images were estimated to be 4 and 1.5 cGy, respectively. Conclusion: Low-dose prophylactic RT to prevent HO around the hip causes a low, but likely biologically meaningful, radiation dose to be delivered to the testicles. This dose could be further reduced by using a medial SBT and photon energies above 6 MV. Testicular shielding should be offered to all male patients receiving such RT. In addition, all patients should be informed about the consequences of testicular radiation as part of their informed consent.",
keywords = "Acetabular fracture, Heterotopic ossification (HO), Indomethacin, Megavoltage photon, Radiation prophylaxis, Radiation therapy (RT), Split-beam technique, Testicular dose",
author = "Mourad, {Waleed Fouad} and Ma, {John K.} and Satyaseelan Packianathan and Weisi Yan and Shaaban, {Sherif G.} and Marchan, {Edward M.} and Abdallah, {Lamiaa E.} and Rei He and Mobit, {Paul N.} and Chunli Yang and Srinivasan Vijayakumar",
year = "2017",
month = "5",
day = "1",
doi = "10.21873/invivo.11084",
language = "English (US)",
volume = "31",
pages = "461--466",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Testicular dose during prophylaxis of heterotopic ossification with radiation therapy

AU - Mourad, Waleed Fouad

AU - Ma, John K.

AU - Packianathan, Satyaseelan

AU - Yan, Weisi

AU - Shaaban, Sherif G.

AU - Marchan, Edward M.

AU - Abdallah, Lamiaa E.

AU - He, Rei

AU - Mobit, Paul N.

AU - Yang, Chunli

AU - Vijayakumar, Srinivasan

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Aim: A single-institution, retrospective study was performed to investigate potential techniques to minimize radiation exposure to the testicles during heterotopic ossification (HO) prophylaxis. We report the impact of splitbeam technique (SBT) and different photon energies on the total dose of radiation received by the testicles during prophylaxis of HO. Materials and Methods: Between 2008 and 2010, we identified 64 patients with traumatic acetabular fractures who underwent surgery followed by radiation therapy (RT) without testicular shielding. Postoperative RT was delivered within 72 h in a single fraction of 700 cGy using 6-18 MV photons, without testicular shielding due to patient refusal. All patients underwent 3-D RT planning in which the testicles were contoured as a region of interest and dosevolume histograms (DVH) were generated. Additional treatment planning trials were created for each patient by utilizing a SBT medially and by using different photon energies (6, 10 and 18 MV) to study the effects of these maneuvers on the delivered dose to the testicles. Results: In reviewing the DVH, it was noted that the mean dose delivered to the testicles was 10 cGy (range=3-40). The maximum dose was 31 cGy (range=7-430). When SBT was utilized, a significant reduction in the mean (44%) and maximum (47%) doses delivered to the testicles was noted. Further reductions in the mean (26%) and maximum (14%) doses were achieved by using higher-energy (10-18 MV) beams. The radiation doses to the testicles from the CT simulation and the two portal images were estimated to be 4 and 1.5 cGy, respectively. Conclusion: Low-dose prophylactic RT to prevent HO around the hip causes a low, but likely biologically meaningful, radiation dose to be delivered to the testicles. This dose could be further reduced by using a medial SBT and photon energies above 6 MV. Testicular shielding should be offered to all male patients receiving such RT. In addition, all patients should be informed about the consequences of testicular radiation as part of their informed consent.

AB - Aim: A single-institution, retrospective study was performed to investigate potential techniques to minimize radiation exposure to the testicles during heterotopic ossification (HO) prophylaxis. We report the impact of splitbeam technique (SBT) and different photon energies on the total dose of radiation received by the testicles during prophylaxis of HO. Materials and Methods: Between 2008 and 2010, we identified 64 patients with traumatic acetabular fractures who underwent surgery followed by radiation therapy (RT) without testicular shielding. Postoperative RT was delivered within 72 h in a single fraction of 700 cGy using 6-18 MV photons, without testicular shielding due to patient refusal. All patients underwent 3-D RT planning in which the testicles were contoured as a region of interest and dosevolume histograms (DVH) were generated. Additional treatment planning trials were created for each patient by utilizing a SBT medially and by using different photon energies (6, 10 and 18 MV) to study the effects of these maneuvers on the delivered dose to the testicles. Results: In reviewing the DVH, it was noted that the mean dose delivered to the testicles was 10 cGy (range=3-40). The maximum dose was 31 cGy (range=7-430). When SBT was utilized, a significant reduction in the mean (44%) and maximum (47%) doses delivered to the testicles was noted. Further reductions in the mean (26%) and maximum (14%) doses were achieved by using higher-energy (10-18 MV) beams. The radiation doses to the testicles from the CT simulation and the two portal images were estimated to be 4 and 1.5 cGy, respectively. Conclusion: Low-dose prophylactic RT to prevent HO around the hip causes a low, but likely biologically meaningful, radiation dose to be delivered to the testicles. This dose could be further reduced by using a medial SBT and photon energies above 6 MV. Testicular shielding should be offered to all male patients receiving such RT. In addition, all patients should be informed about the consequences of testicular radiation as part of their informed consent.

KW - Acetabular fracture

KW - Heterotopic ossification (HO)

KW - Indomethacin

KW - Megavoltage photon

KW - Radiation prophylaxis

KW - Radiation therapy (RT)

KW - Split-beam technique

KW - Testicular dose

UR - http://www.scopus.com/inward/record.url?scp=85018719161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018719161&partnerID=8YFLogxK

U2 - 10.21873/invivo.11084

DO - 10.21873/invivo.11084

M3 - Article

VL - 31

SP - 461

EP - 466

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 3

ER -